My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

BioCryst Pharmaceuticals, Inc. - Common Stock (NQ:BCRX)

7.570 -0.010 (-0.13%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 12, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioCryst Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate ↗

August 04, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

BioCryst Pharmaceuticals: Q2 Earnings Insights ↗

August 04, 2022

BioCryst Pharmaceuticals (NASDAQ:BCRX) reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Alibaba, MercadoLibre And Some Other Big Stocks Moving Higher In Today's Pre-Market Session ↗

August 04, 2022

Via Benzinga

Stocks Rally as Major Indexes Look to End Losing Streaks ↗

June 24, 2022

All three major indexes are set to snap three consecutive weeks of losses on Friday, as stocks surge midday.

Via Talk Markets

BioCryst's Voluntary Pause Of Rare Blood Disorder Trial Turns Into FDA Clinical Hold ↗

May 05, 2022

Via Benzinga

Read Here Why Did BioCryst Stopped Enrollment In BCX9930 Studies In Rare Blood Disorder ↗

April 08, 2022

Via Benzinga

BioCryst Gets FDA Fast Track Designation For Bone Formation Disorder Candidate ↗

June 08, 2022

The U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to BioCryst Pharmaceuticals's (NASDAQ: BCRX) lead drug candidate BCX9250 for the prevention of heterotopic ossification...

Via Benzinga

The Daily Biotech Pulse: FDA Adcomm Backing For Novavax's COVID-19 Shot, New Data On Moderna's Omicron Vaccine, DBV Tech's Encouraging Peanut Allergy Trial Data ↗

June 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

7 Cheap Biotech Stocks to Buy Now ↗

May 19, 2022

These biotech stocks can be speculative, but have the potential to blow up in the next couple of years for good gains.

Via InvestorPlace

9 Health Care Stocks With Whale Alerts In Today's Session ↗

May 18, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study ↗

May 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Recap: BioCryst Pharmaceuticals Q1 Earnings ↗

May 05, 2022

BioCryst Pharmaceuticals (NASDAQ:BCRX) reported its Q1 earnings results on Thursday, May 5, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 02, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis ↗

April 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

7 Top-Rated Biotech Stocks to Buy for Q2 ↗

April 21, 2022

In these tumultous economic times, look to sectors that are outside the turmoil. Each of these seven biotech stocks fit the bill.

Via InvestorPlace

What 4 Analyst Ratings Have To Say About BioCryst Pharmaceuticals ↗

April 18, 2022

Within the last quarter, BioCryst Pharmaceuticals (NASDAQ:BCRX) has observed the following analyst ratings:

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2022 ↗

April 18, 2022

Upgrades

Via Benzinga

28 Biggest Movers From Yesterday ↗

April 14, 2022

Gainers HighPeak Energy, Inc. (NASDAQ: HPK) shares gained 31.76% to close at $28.83 on Wednesday, after CNBC’s Jim Cramer said the mid-cap company is an aggressive play on...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

April 11, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Oppenheimer Maintains Outperform Rating for BioCryst Pharmaceuticals, Lowers Price Target To $16 ↗

April 11, 2022

Oppenheimer has decided to maintain its Outperform rating of BioCryst Pharmaceuticals (NASDAQ:BCRX) and lower its price target from $20.00 to $16.00. Shares of BioCryst Pharmaceuticals are trading down...

Via Benzinga

Why BioCryst Pharmaceuticals Stock Is Falling ↗

April 11, 2022

BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) shares are trading lower Monday morning after BofA Securities downgraded the stock and Oppenheimer lowered its price target.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 11, 2022 ↗

April 11, 2022

Upgrades

Via Benzinga

Mid-Afternoon Market Update: Nasdaq Falls 150 Points; Crude Oil Rises 2% ↗

April 08, 2022

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite dropping more than 100 points on Friday.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 08, 2022

Gainers Phio Pharma (NASDAQ:PHIO) shares increased by 46.7% to $1.33 during Friday's regular session. As of 13:31 EST, Phio Pharma's stock is trading at a volume...

Via Benzinga

28 Stocks Moving In Friday's Mid-Day Session ↗

April 08, 2022

Gainers Lyra Therapeutics, Inc. (NASDAQ: LYRA) shares climbed 33.3% to $5.78 as the company reported a private placement for gross proceeds of $110.5 million. TSR, Inc. (NASDAQ...

Via Benzinga

10 Health Care Stocks Whale Activity In Today's Session ↗

April 08, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Mid-Day Market Update: Dow Jumps Over 200 Points; Sunshine Biopharma Shares Slide ↗

April 08, 2022

U.S. stocks traded mixed midway through trading, with the Dow Jones surging more than 200 points on Friday.

Via Benzinga

Mid-Morning Market Update: Markets Edge Lower; US Wholesale Inventories Rise 2.5% In February ↗

April 08, 2022

U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping 100 points on Friday.

Via Benzinga

Why BioCryst Pharmaceuticals Stock Is Plunging Today ↗

April 08, 2022

BioCryst Pharmaceuticals Inc (NASDAQ: BCRX) shares are trading significantly lower Friday after the company paused enrollment in clinical trials with BCX9930 while it ...

Via Benzinga

Biocryst Pharmaceuticals Stock Shows Rising Price Performance With Jump To 92 RS Rating ↗

March 23, 2022

Biotech Biocryst Pharmaceuticals stock had its Relative Strength (RS) Rating upgraded from 88 to 92 Wednesday.

Via Investor's Business Daily

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.